QuintilesIMS delivers integrated information and technology solutions to drive healthcare forward.
With a global team of 50,000, we harness insights, commercial and scientific depth, and executional expertise to empower clients to achieve some of their most important goals: Improving clinical, scientific and commercial results. Realizing the full potential of innovations. And, ultimately, driving healthcare forward.
October 3, 2016 : QuintilesIMS starts a new chapter as a publicly traded company (NYSE:Q). The company’s 50,000 professionals serve clients in 100+ markets—working to advance healthcare by seamlessly connecting clinical and commercial execution to real-world outcomes.
May 3, 2016 : IMS and Quintiles announce intention to merge to create a global leader in healthcare intelligence.
2015 : IMS acquires Cegedim’s CRM business and strategic data assets—affirming its position as the first global enterprise focused on connecting solutions across information, technology and services to drive healthcare performance.
2013 : IMS completes a series of strategic acquisitions to strengthen technology services and solutions—including social media listening, multichannel marketing and performance management, as well as technology-enabled Real-World Insights solutions.
2011 : Quintiles acquires Outcome Sciences, positioning Quintiles as the industry powerhouse in late-phase and real-world research. IMS expands specialty and anonymized patient-level data assets in the U.S. with the acquisition of SDI Health.
2003 : Quintiles becomes a private company led by founder and Chairman Dennis Gillings, CBE, PhD.
1996 Commercial Strength : Quintiles combines with Innovex Ltd., a UK-based contract pharmaceutical company specializing in sales and marketing services for major pharma companies. The addition of Innovex makes Quintiles the world's largest full-service biopharmaceutical services company and enables Quintiles to provide services across the product lifecycle.
1996 Adds Consulting : Quintiles establishes its Consulting practice with the acquisition of a globally recognized healthcare policy research and management consulting company.
1994 : Quintiles goes public, completing an initial public offering of Quintiles stock.
1993 Asia Arrival : Quintiles establishes operations in Asia, opening in Tokyo to extend services to Japanese customers. Today, Quintiles Asia spans the continent, opening in about 20 cities.
1992 : Quintiles Laboratories Ltd. opens in Atlanta, expanding from one small room offering safety testing to a global network with a full-service offering, before becoming Q2LabSolutions in a transaction with Quest Diagnostics.
1987 Goes Global : Quintiles begins its global expansion, opening its United Kingdom operations to serve customers in Europe
1982 Quintiles Foundation : Dennis Gillings, London-born professor at the University of North Carolina (UNC), signs his first consulting contract. His team of part-time staff working in a trailer on the UNC campus provides statistical and data management consulting for pharmaceutical customers. Quintiles is formally incorporated in North Carolina, co-founded by Gillings and Gary Koch.
1954 IMS Foundation : Bill Frohlich, an ad executive, and David Dubow, a visionary, form IMS as the first independent, objective source of information about the pharmaceutical industry.
Bringing people and knowledge together for a healthier world by operating through the following major business units:
Quintiles Srl: a Clinical Research Organization that provides support to the pharmaceutical, biotechnology, and medical device industries in conducting clinical studies. We work with international, multifunctional project teams, involving Feasibility & Site-ID Specialists, Start Up & Regulatory Specialist, Regulatory & Start Up Leads, Clinical Leads, Project Managers, Quality Specialist, CRAs and CTAs.
Quintiles Commercial Italia srl: offers outsourcing tools for the promotion and commercialisation of new and mature products and activation of specialised lines, sales representative recruitment and vacancy management via agreements with the most important players in the sector.
Temas Srl: supports Biopharmaceutical companies by identifying the most suitable market access approach that best fits the Payers requirement and gives the fastest access in the local markets.
Through in-depth knowledge of regional/local healthcare policies and decision making processes Temas favours the collaboration between Industry and Payers to benefit the healthcare system.
Quintiles Staff Services: established in 1998 in Italy, authorised to operate as a Temporary Employment Agency, it provides efficient selection and recruitment services, profiling graduates to positions with several years’ experience in scientific fields
The more minds that contribute, the better the results. We work together across the hall and across the globe, collaborating actively to solve tough challenges and advance our collective goals.
Leadership is a state of action, empowering decision-makers at every level. Moving forward with purpose, to create value today and build a legacy for tomorrow.
We build lasting, collaborative relationships with our customers. It starts with a deep understanding of the challenges they face. Working as their thought partner, we help them turn their vision into reality.
At the heart of our work is doing what’s right – for patients, customers and employees. We act with an unwavering commitment to ethics, honesty and accountability.
We’re passionate about what we do and we want our name to stand for excellence. We are determined to be the example that the industry aspires to follow.
CRA- Clinical Research
Senior CRA- Clinical Research Associate